Titan Spine Reaches 18k Implantations of Endoskeleton Interbody Fusion Device

Mequon, Wis.-based Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device.

Advertisement

The company is approaching an annualized sales revenue run-rate of $20 million.

Titan Spine has been growing steadily over the past 12 months, and recently signed a distribution agreement with Biomet.

More Articles on Supply Chain:
Mitek Sports Medicine Launches RIGIDFIX ACL Reconstruction System
Alphatec Spine Loses $14.5M in Q3 After PurGen Device Discontinuation
DMP Spine Biologics to Distribute Bacterin Bone Graft Products in Europe

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.